The promise of a simple blood test that only required a few drops of blood, but would accurately give the result of hundreds of blood test was too good to pass up on. It allowed Theranos to raise hundreds of millions of dollars and achieve a valuation of billions of dollars. Only problem: their tech doesn’t exist and never did. Now that the SEC has gotten involved, we figured we’d finally give our opinion on the whole ordeal.
210: Recapping Google’s iPhone Event
This week we spend time diving into Google’s hardware announcements. Their phones look interesting and the Pixel tablet is particularly interesting (if you can handle the price). Overall Google continues to make solid improvements to their hardware offerings. Check below for all the stories we cover in this episode.